Oxford Events, the new replacement for OxTalks, will launch on 16th March. The two-week OxTalks freeze period starts on Monday 2nd March. During this time, there will be no facility to publish or edit events. The existing OxTalks site will remain available to view during this period. Once Oxford Events launches, you will need a Halo login to submit events. Full details are available on the Staff Gateway.
Increasing rates of autoimmune and inflammatory disease present a burgeoning threat to human health. This is compounded by the limited efficacy of available treatments and high failure rates during drug development – highlighting an urgent need to better understand disease mechanisms. I will discuss our recent work that shows how functional genomics can address this challenge. By investigating an intergenic haplotype on chr21q22, independently linked to inflammatory bowel disease, ankylosing spondylitis, primary sclerosing cholangitis and Takayasu’s arteritis, we discover a central regulator of inflammatory responses in human macrophages and delineate a shared disease mechanism that can be targeted therapeutically.
